Search company, investor...


Founded Year


About ADcom

Provider of a system for measuring cable television audiences and reporting the viewership data. The company's ratings are based on data from metered panel homes that is cross-referenced with product consumption data from samples. The resulting data, translated into ratings reports, graphs, and charts can be used by advertisers, advertising agencies, and cable systems to report ratings, demographic levels, product usage, buying habits, socio-economic levels, and lifestyles.

Headquarters Location

700 West Hillsboro Boulevard Building 3, Suite 201

Deerfield Beach, Florida, 33441,

United States


Missing: ADcom's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ADcom's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest ADcom News

Intercept Shares Tumble Premarket After Negative FDA AdCom Vote

May 22, 2023

05/19 05/22/2023 | 07:43am EDT Message : By Colin Kellaher Intercept Pharmaceuticals shares moved lower in premarket trading Monday after the biopharmaceutical company's latest setback in its bid to win U.S. Food and Drug Administration approval of obeticholic acid as a treatment for pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis, a chronic liver condition commonly known as NASH. Shares of the Morristown, N.J., company, which closed Thursday at $13.56, were recently down 14% at $11.66 in premarket trading. Trading in the stock was halted all day Friday. An FDA advisory committee meeting on Friday voted overwhelmingly that the drug's benefits don't outweigh its risks, and that the agency should defer approval under an accelerated pathway based on currently available data until data from an ongoing study are submitted and reviewed. The FDA in 2020 rejected Intercept's initial application for obeticholic acid, saying the company's efficacy data didn't sufficiently outweigh potential risks. Intercept conducted additional studies and resubmitted the application in December, seeking an accelerated approval. The agency has set a target action date of June 22 for a decision. The FDA often relies on advisory committees to provide independent advice when a scientific, technical or policy question arises, such as whether an unapproved product is safe and effective, and the panels make non-binding recommendations that the agency generally follows, although it isn't legally bound to do so. There are currently no FDA-approved products for NASH, a progressive disease that is a leading cause for the need for liver transplants. Write to Colin Kellaher at (END) Dow Jones Newswires

ADcom Frequently Asked Questions (FAQ)

  • When was ADcom founded?

    ADcom was founded in 1994.

  • Where is ADcom's headquarters?

    ADcom's headquarters is located at 700 West Hillsboro Boulevard, Deerfield Beach.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.